Go Pro

Boundless Bio (BOLD) Institutional Ownership

Boundless Bio logo
$2.78 0.00 (0.00%)
As of 10:43 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Boundless Bio (NASDAQ:BOLD)

Number of
Institutional Buyers
(last 12 months)
9
Total
Institutional Inflows
(last 12 months)
$915.76K
Number of
Institutional Sellers
(last 12 months)
3
Total
Institutional Outflows
(last 12 months)
$275.61K
Get BOLD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Boundless Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

BOLD Institutional Buying and Selling by Quarter

Boundless Bio Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/7/2026 BlackRock Inc.88,495$221K0.0%N/A0.394%
8/6/2026 GSA Capital Partners LLP72,353$181K0.0%N/A0.322%
5/14/2026Renaissance Technologies LLC399,000$439K0.0%+16.9%1.776%
2/18/2026XTX Topco Ltd39,577$47K0.0%+36.1%0.177%
2/18/2026Millennium Management LLC135,410$162K0.0%-17.5%0.605%
2/16/2026 Landscape Capital Management L.L.C.127,626$153K0.0%N/A0.570%
2/12/2026Renaissance Technologies LLC341,400$410K0.0%+52.7%1.525%
11/17/2025Millennium Management LLC164,091$202K0.0%-23.2%0.733%
11/17/2025Citadel Advisors LLC876,412$1.08M0.0%+5.5%3.914%
11/17/2025Almitas Capital LLC86,808$107K0.0%-63.1%0.388%
11/14/2025Squarepoint Ops LLC50,771$62K0.0%+175.9%0.227%
8/15/2025Bridgeway Capital Management LLC50,500$51K0.0%N/A0.226%
8/14/2025Redmile Group LLC589,034$595K0.1%-18.8%2.631%
8/14/2025RBF Capital LLC200,000$202K0.0%N/A0.893%
8/13/2025Stonepine Capital Management LLC106,175$107K0.1%N/A0.474%
8/12/2025XTX Topco Ltd40,064$40K0.0%+54.6%0.179%
8/8/2025 Geode Capital Management LLC58,903$59K0.0%-76.2%0.263%
8/1/2025 Y Intercept Hong Kong Ltd55,242$56K0.0%N/A0.247%
6/27/2025Goldman Sachs Group Inc.34,427$52K0.0%-29.3%0.154%
5/12/2025Nuveen LLC3,958,413$5.98M0.0%N/A17.751%


BOLD Institutional Ownership - Frequently Asked Questions

During the previous two years, 17 institutional investors and hedge funds held shares of Boundless Bio. The most heavily invested institutionals were Nuveen LLC ($5.98M), Citadel Advisors LLC ($1.08M), Redmile Group LLC ($595K), Renaissance Technologies LLC ($439K), BlackRock Inc. ($221K), RBF Capital LLC ($202K), and GSA Capital Partners LLP ($181K).Learn more on Boundless Bio's institutional investors.

Of the 12 institutional investors that purchased Boundless Bio's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Nuveen LLC ($3.96M), RBF Capital LLC ($200K), Renaissance Technologies LLC ($175.44K), Landscape Capital Management L.L.C. ($127.63K), Stonepine Capital Management LLC ($106.18K), BlackRock Inc. ($88.50K), and GSA Capital Partners LLP ($72.35K).

Institutional investors have bought a total of 602,756 shares in the last 24 months. This purchase volume represents approximately $915.76K in transactions.

The following institutional investors have sold Boundless Bio stock in the last 24 months: Almitas Capital LLC ($148.70K), and Millennium Management LLC ($78.15K).

Institutional investors have sold a total of 226,848 shares in the last 24 months. This volume of shares sold represents approximately $275.61K in transactions.



Institutional ownership data for NASDAQ:BOLD is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 8/7/2026. New 13F filings are added each quarter as they're published.
From Our Partners